{"entity":{"type":"insider","cik":"0001823187","url":"/insider/0001823187","json_url":"/insider/0001823187.json","name":"King Andrew James","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":13,"first":"2021-11-12","last":"2023-08-01","span_basis":"filed_date"},"name_variants":[{"name":"King Andrew James","source":"filing","n_filings":13,"first_seen":"2021-11-12","last_seen":"2023-08-01"}],"transactions":[{"id":8629913,"accession":"0001209191-23-044071","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-044071","line_url":"/filing/0001209191-23-044071#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1168.0,"shares_display":"1,168","price_per_share":39.029,"price_display":"39.03","price_state":"stated","total_value":45585.872,"total_display":"45,585.87","total_whole":"45,586","shares_owned_after":19157.0,"shares_owned_after_display":"19,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-08-01","filed_date":"2023-08-01","scope":"insider"},{"id":8437861,"accession":"0001209191-23-023351","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-023351","line_url":"/filing/0001209191-23-023351#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":23.3435,"price_display":"23.34","price_state":"stated","total_value":116717.5,"total_display":"116,717.50","total_whole":"116,718","shares_owned_after":16992.0,"shares_owned_after_display":"16,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":8070521,"accession":"0001209191-23-009766","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-009766","line_url":"/filing/0001209191-23-009766#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2392.0,"shares_display":"2,392","price_per_share":23.7485,"price_display":"23.75","price_state":"stated","total_value":56806.412,"total_display":"56,806.41","total_whole":"56,806","shares_owned_after":19492.0,"shares_owned_after_display":"19,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-02-10","filed_date":"2023-02-15","scope":"insider"},{"id":8605489,"accession":"0001209191-23-006371","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-006371","line_url":"/filing/0001209191-23-006371#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3244.0,"shares_display":"3,244","price_per_share":24.6822,"price_display":"24.68","price_state":"stated","total_value":80069.0568,"total_display":"80,069.06","total_whole":"80,069","shares_owned_after":15081.0,"shares_owned_after_display":"15,081","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-31","filed_date":"2023-02-02","scope":"insider"},{"id":7966743,"accession":"0001209191-23-001434","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-23-001434","line_url":"/filing/0001209191-23-001434#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":25.8183,"price_display":"25.82","price_state":"stated","total_value":258183.0,"total_display":"258,183.00","total_whole":"258,183","shares_owned_after":9992.0,"shares_owned_after_display":"9,992","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-03","filed_date":"2023-01-04","scope":"insider"},{"id":6613679,"accession":"0001209191-22-053301","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-053301","line_url":"/filing/0001209191-22-053301#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3557.0,"shares_display":"3,557","price_per_share":19.692,"price_display":"19.69","price_state":"stated","total_value":70044.444,"total_display":"70,044.44","total_whole":"70,044","shares_owned_after":12492.0,"shares_owned_after_display":"12,492","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-10-06","filed_date":"2022-10-11","scope":"insider"},{"id":6753219,"accession":"0001209191-22-044596","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-044596","line_url":"/filing/0001209191-22-044596#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":100000.0,"total_display":"100,000.00","total_whole":"100,000","shares_owned_after":5897.0,"shares_owned_after_display":"5,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-08-04","filed_date":"2022-08-05","scope":"insider"},{"id":6126124,"accession":"0001209191-22-042041","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-042041","line_url":"/filing/0001209191-22-042041#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":18.0936,"price_display":"18.09","price_state":"stated","total_value":90468.0,"total_display":"90,468.00","total_whole":"90,468","shares_owned_after":5897.0,"shares_owned_after_display":"5,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-11","filed_date":"2022-07-13","scope":"insider"},{"id":6924525,"accession":"0001209191-22-024324","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-024324","line_url":"/filing/0001209191-22-024324#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.3624,"price_display":"15.36","price_state":"stated","total_value":76812.0,"total_display":"76,812.00","total_whole":"76,812","shares_owned_after":5897.0,"shares_owned_after_display":"5,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-04-11","filed_date":"2022-04-13","scope":"insider"},{"id":6668277,"accession":"0001209191-22-012315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-22-012315","line_url":"/filing/0001209191-22-012315#line-1","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":32500.0,"total_display":"32,500.00","total_whole":"32,500","shares_owned_after":5897.0,"shares_owned_after_display":"5,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6423817,"accession":"0001209191-22-009564","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-009564","line_url":"/filing/0001209191-22-009564#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2498.0,"shares_display":"2,498","price_per_share":12.7411,"price_display":"12.74","price_state":"stated","total_value":31827.2678,"total_display":"31,827.27","total_whole":"31,827","shares_owned_after":8397.0,"shares_owned_after_display":"8,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-11","filed_date":"2022-02-14","scope":"insider"},{"id":6423759,"accession":"0001209191-22-008937","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-008937","line_url":"/filing/0001209191-22-008937#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":13.31,"price_display":"13.31","price_state":"stated","total_value":33275.0,"total_display":"33,275.00","total_whole":"33,275","shares_owned_after":4094.0,"shares_owned_after_display":"4,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-10","filed_date":"2022-02-11","scope":"insider"},{"id":5055817,"accession":"0001209191-21-064363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-064363","line_url":"/filing/0001209191-21-064363#line-2","is_derivative":false,"issuer_cik":"0001435049","issuer_name":"CHINOOK THERAPEUTICS, INC.","issuer_ticker":"KDNY","issuer_name_source":null,"issuer_url":"/issuer/0001435049","owner_cik":"0001823187","owner_name":"King Andrew James","owner_display_name":"King Andrew James","owner_url":"/insider/0001823187","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":13.5319,"price_display":"13.53","price_state":"stated","total_value":67659.5,"total_display":"67,659.50","total_whole":"67,660","shares_owned_after":4094.0,"shares_owned_after_display":"4,094","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-09","filed_date":"2021-11-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001435049","name":"CHINOOK THERAPEUTICS, INC.","url":"/issuer/0001435049","role":"Officer (Chief Scientific Officer)","n_filings":13,"first_seen":"2021-11-12","last_seen":"2023-08-01"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001823187","retrieved_at":"2026-08-23T15:58:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}